Cited by 21Advanced Glycation End Products researchDiabetes Management and ResearchGlycosylation and Glycoproteins Research

Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: Relationship to diabetic complications and glycaemic control

Open access
Waters, P. J., Flynn, M. D., Corrall, R. J. M., Pennock, C. A.·1992·Diabetologia

Abstract

Lysosomal enzymes degrade membrane glycoconjugates, and increased circulating enzyme activity may be an important mechanism in the pathogenesis of diabetic microangiopathy. We have assayed a profile of seven lysosomal enzyme activities (nmol.h-1.ml-1) in platelet-free plasma from 54 Type 1 (insulin-dependent) diabetic subjects (median age 31 years) and 42 matched normal control subjects. A significant increase in median (interquartile range) enzyme activity was measured in diabetic compared to control subjects for beta-D-glucuronidase, 121 (97.7-171) vs 88.8 (62.8-113), p less than 0.001; beta-D-Nacetylglucosaminidase, 693 (568-799) vs 568 (462-686), p less than 0.001; alpha-D-mannosidase, 23.8 (16.7-28.9) vs 14.5 (10.1-20.0), p less than 0.001; and beta-D-galactosidase, 6.94 (6.11-9.99) vs 6.66 (4.78-8.33), p less than 0.04. In contrast, alpha-L-fucosidase, alpha-D-galactosidase and beta-D-mannosidase activities were similar in diabetic and control subjects. None of the enzyme activities differed significantly (p less than 0.05) between 24 diabetic patients with clinical complications and 30 complication-free diabetic patients with similar glycaemic control which does not support the hypothesis that enzyme increases in diabetes arise simply by leakage from damaged tissues. In the diabetic subjects HbA1, median (interquartile range) 9.10 (7.40-10.60), was significantly related to beta-D-glucuronidase (rs = 0.56, p less than 0.001) and beta-D-Nacetylglucosaminidase (rs = 0.55, p less than 0.001). We have therefore demonstrated in diabetic subjects an increase in certain lysosomal glycosidases, that correlates with glycaemic control.(ABSTRACT TRUNCATED AT 250 WORDS)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf00401431

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Barnes ID (1978) Enzyme abnormalities in bone dysplasias, doc- toral thesis. University of Bristol, Bristol, pp 115-169

Cited by

Sorted by citations

Authors
Waters, P. J., Flynn, M. D., Corrall, R. J. M., & Pennock, C. A.
Affiliations
  • St Michael's Hospital (GB)
  • Bristol Royal Infirmary (GB)
Venue
Diabetologia
Published
1992-10
Volume
35
Issue
10
Pages
991-995
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1964400878
Cited by
21
References
22
Citations by year
2020: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2013: 1 · 2012: 1
FWCI
1.67
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
type 1 diabetes, lysosomal enzymes, plasma enzyme activity, glycoside hydrolases, beta-glucuronidase, alpha-mannosidase, beta-galactosidase, glycemic control, HbA1, diabetes complications, diabetic microangiopathy, platelet-free plasma
MeSH terms
Acetylglucosaminidase, Adolescent, Adult, Aged, beta-Galactosidase, Blood Glucose, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Female, Glucuronidase, Glycated Hemoglobin, Humans, Lysosomes, Male, Mannosidases, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review